These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1619031)

  • 1. Will postpartum recurrence of Graves' hyperthyroidism become a thing of the past?
    Singer PA
    J Clin Endocrinol Metab; 1992 Jul; 75(1):5A-5B. PubMed ID: 1619031
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.
    Hashizume K; Ichikawa K; Nishii Y; Kobayashi M; Sakurai A; Miyamoto T; Suzuki S; Takeda T
    J Clin Endocrinol Metab; 1992 Jul; 75(1):6-10. PubMed ID: 1642700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
    Bunevicius R; Velickiene D; Prange AJ
    Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerperal cerebral sinus venous thrombosis and acute hyperthyroidism in Graves' disease.
    Migeot M; Rutgers MP; Gille M
    Acta Neurol Belg; 2013 Sep; 113(3):331-3. PubMed ID: 23625777
    [No Abstract]   [Full Text] [Related]  

  • 6. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
    Momotani N; Noh J; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):285-9. PubMed ID: 7913091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of hyperthyroidism caused by Graves' disease; a decisional approach].
    Schaper NC; Hunink MG; Casparie AF
    Ned Tijdschr Geneeskd; 1986 Aug; 130(32):1443-50. PubMed ID: 2430195
    [No Abstract]   [Full Text] [Related]  

  • 9. Painless thyroiditis and transient thyrotoxicosis after Graves' disease.
    Check JH; Avellino J
    JAMA; 1980 Sep; 244(12):1361. PubMed ID: 6893345
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N; Miyai K; Yamamoto T; Kuro R; Tanaka F
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K
    Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of therapy for Graves' hyperthyroidism.
    Becker DV
    N Engl J Med; 1984 Aug; 311(7):464-6. PubMed ID: 6547768
    [No Abstract]   [Full Text] [Related]  

  • 13. New-onset Graves' disease in the postpartum period.
    Goldstein AL
    J Midwifery Womens Health; 2013; 58(2):211-4. PubMed ID: 23590488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
    Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves' disease as probable etiology based on follow-up observations.
    Sandler R
    J Clin Endocrinol Metab; 1976 Jan; 42(1):163-8. PubMed ID: 814132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does thyroxine therapy prevent recurrence of Graves' hyperthyroidism?
    Hershman JM
    J Clin Endocrinol Metab; 1995 May; 80(5):1479-80. PubMed ID: 7744988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long term follow-up after thyroidectomy].
    Scazziga BR
    Helv Chir Acta; 1978 Jan; 44(5-6):741-5. PubMed ID: 580089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversible hyperthyroidism caused by painless postpartum thyroiditis].
    Heim J
    Sem Hop; 1983 May; 59(20):1553-5. PubMed ID: 6308780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.